Basal | 2 months | p | |
---|---|---|---|
A. Soy beverage 1 (250 mL/day) | |||
Lipid profile (mg/dL) | |||
Total cholesterol | 183.7 ± 29.1 | 183.4 ± 27.4 | 0.879 |
LDL | 109.0 ± 26.1 | 107.4 ± 26.3 | 0.367 |
HDL | 68.3 ± 11.4 | 70.3 ± 10.4 | 0.124 |
Triglycerides | 96.2 ± 43.0 | 95.9 ± 37.1 | 0.954 |
Blood pressure (mmHg) | |||
Systolic | 122 ± 13 | 118 ± 9 | 0.042 |
Diastolic | 82 ± 11 | 76 ± 7 | 0.006 |
Inflammation biomarkers (pg/mL) | |||
TNFα | 4.5 ± 1.3 | 4.3 ± 1.4 | 0.447 |
MCP-1 | 321 ± 96 | 313 ± 98 | 0.548 |
Vitamin D (ng/mL) | |||
25 D3 | 18.0 ± 5.6 | 25.0 ± 5.4 | <0.001 |
1,25 D3 | 0.32 ± 0.10 | 0.32 ± 0.11 | 0.468 |
24R,25 D3 | 2.3 ± 1.5 | 2.6 ± 1.8 | 0.823 |
B. Soy beverage 2 (500 mL/day) | |||
Lipid profile (mg/dL) | |||
Total cholesterol | 180.3 ± 29.2 | 179.6 ± 30.0 | 0.820 |
LDL | 107.1 ± 25.2 | 105.2 ± 24.6 | 0.482 |
HDL | 68.5 ± 12.4 | 71.0 ± 12.6 | 0.111 |
Triglycerides | 79.9 ± 25.7 | 74.7 ± 17.5 | 0.323 |
Blood pressure (mmHg) | |||
Systolic | 120 ± 9 | 116 ± 10 | 0.075 |
Diastolic | 75 ± 7 | 74 ± 8 | 0.310 |
Inflammation biomarkers (pg/mL) | |||
TNFα | 4.8 ± 1.6 | 4.6 ± 1.4 | 0.306 |
MCP-1 | 334 ± 82 | 339 ± 88 | 0.638 |
Vitamin D (ng/mL) | |||
25 D3 | 20.5 ± 6.3 | 26.0 ± 5.2 | <0.001 |
1,25 D3 | 0.29 ± 0.12 | 0.34 ± 0.11 | 0.498 |
24R,25 D3 | 2.8 ± 1.4 | 2.6 ± 1.3 | 0.050 |
C. Control | |||
Lipid profile (mg/dL) | |||
Total cholesterol | 176.4 ± 29.6 | 176.8 ± 32.3 | 0.883 |
LDL | 104.6 ± 26.6 | 101.0 ± 26.9 | 0.154 |
HDL | 64.6 ± 13.8 | 66.9 ± 13.0 | 0.077 |
Triglycerides | 93.3 ± 37.8 | 98.9 ± 43.5 | 0.604 |
Blood pressure (mmHg) | |||
Systolic | 124 ± 13 | 116 ± 12 | 0.003 |
Diastolic | 75 ± 10 | 73 ± 8 | 0.624 |
Inflammation biomarkers (pg/mL) | |||
TNFα | 4.0 ± 1.2 | 4.2 ± 1.3 | 0.042 |
MCP-1 | 308 ± 103 | 320 ± 107 | 0.266 |
Vitamin D (ng/mL) | |||
25 D3 | 20.3 ± 6.0 | 21.2 ± 5.5 | 0.251 |
1,25 D3 | 0.42 ± 0.08 | 0.35 ± 0.08 | 0.497 |
24R,25 D3 | 3.1 ± 0.7 | 2.8 ± 1.2 | 0.096 |